Pediatric Pharmacy Specialty Review Course for Recertification + RECERT EXAMS Package (Cert # L239306)

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.  

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in pediatric pharmacy.

Board certified pharmacists are eligible to receive up to 25.50 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment. 

This course is not intended for those preparing to take the BPS Pediatric Pharmacy Specialty Examination for Certification. To prepare for the examination, please see courses here: http://elearning.ashp.org/catalog/pediatric-review.

These activities are part of the ASHP professional development program for BCPPS recertification approved by the BPS.

* Please note: Review Course for Recertification may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle.

At the end of the presentations, the pharmacist should be able to:                                                   

Complex Case: Deep Vein Thrombosis and Metabolic Syndrome
ACPE Number: 0204-0000-23-983-H01-P

• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including deep vein thrombosis, type 2 diabetes mellitus, dyslipidemia, and hypertension.
• Identify resources and treatment options for sexually transmitted infections.
• Select appropriate monitoring considerations of anticoagulation medications.
• Recognize the impact of pharmacogenomic differences on warfarin therapy. 

Select Topics in Pediatric Cardiovascular Disease
ACPE Number: 0204-0000-23-984-H01-P

• Interpret signs, symptoms and diagnostic tests in a pediatric patient with congenital heart disease (specifically VSD, ASD, TOF, coarctation of aorta, and hypoplastic left heart) or Kawasaki disease.
• Identify drug-related problems, including drug interactions.
• Develop the most appropriate therapy and monitoring plans based on patient-specific information and the most current guidelines.
• Use PALS to determine appropriate therapy for bradycardia and tachycardia. 

Complex Case: Neonatal Sepsis
ACPE Number: 0204-0000-23-985-H01-P

• Develop appropriate treatment and monitoring plans for a complex neonatal patient with multiple conditions, including patent ductus arteriosus, apnea of prematurity, early and late onset sepsis, and necrotizing enterocolitis.
• Evaluate the clinical and therapeutic implications of placental transfer of medications.
• Identify age-specific pharmacokinetic differences among neonates, infants, children, and adolescents.
• Apply FDA alerts for adverse drug events and drug-drug interactions into clinical practice.
• Identify characteristics that facilitate transfer of medications into the breast milk. 

Select Topics in Pediatric Nutrition
ACPE Number: 0204-0000-23-986-H01-P

• Evaluate if nutrition needs of a pediatric patient are being met based on assessment of appropriate growth and development.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with parenteral and enteral nutrition needs.
• Evaluate patients for weight (overweight or obese) based on current guidelines. 

Complex Case: Sickle Cell Disease with Vaso-Occlusive Crisis
ACPE Number: 0204-0000-23-987-H01-P

• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including a vaso-occlusive crisis, cellulitis, constipation, and need for immunizations.
• Select most appropriate patient-controlled analgesia regimen based on vaso-occlusive crisis severity.
• Apply pharmacodynamic principles when selecting appropriate antibiotic regimens.
• Identify required immunizations for adolescents, including patients with risk factors for vaccine-preventable diseases. 

Complex Case: Acute Lymphoblastic Leukemia with Tumor Lysis Syndrome
ACPE Number: 0204-0000-23-988-H01-P

• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including acute lymphoblastic leukemia (ALL), tumor lysis syndrome, febrile neutropenia, invasive aspergillosis infection, and Clostridium difficile infection.
• Select appropriate medication dose modifications related to hepatic impairment. 

Select Topics in Pediatric Hematology and Oncology
ACPE Number: 0204-0000-23-989-H01-P

• Interpret signs, symptoms and diagnostic tests for chemotherapy-induced nausea and vomiting, mucositis, immune thrombocytopenia, infantile hemangioma, and palliative care in pediatric cancer patients.
• Evaluate patient information to identify drug-related problems and response to therapy.
• Identify appropriate modifications and supportive care plans based on patient-specific follow up assessment. 

Complex Case: Medication Error & Practice Management
ACPE Number: 0204-0000-23-990-H05-P

Incorporate position statements, white papers, national guidelines from recognized regulatory organizations into institutional policies and procedures related to:

• Medication reconciliation
• Appropriate drug preparation and delivery (e.g., extemporaneous compounding and standardized concentrations)
• Selection of appropriate equipment/technology and decision support
• Adverse drug event monitoring and reporting, or
• Metrics for evaluating quality of pediatric pharmacy services. 

Complex Case: Acute Asthma
ACPE Number: 0204-0000-23-991-H01-P

• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including acute and chronic asthma, ADHD, acne and GERD.
• Evaluate essential components of social history, including smoke exposure and home environment.
• Formulate a plan to address barriers to patient education and adherence, including age, language, cultural considerations, and inhaler technique.
• Describe the impact of age on classification and management of asthma.
• Assess available resources to improve access to medications, including patient assistance programs. 

Select Topics in Pediatric Pulmonary Disease
ACPE Number: 0204-0000-23-992-H01-P

For the following specific pulmonary topics: cystic fibrosis (exacerbation management) and chronic asthma management

• Interpret relevant clinical and laboratory data and results of diagnostic procedures in a pediatric patient with an exacerbation of cystic fibrosis or chronic asthma.
• Identify relevant differences in laboratory sampling for pediatric patients (e.g., blood volume; method, frequency, and timing of sampling).
• Develop the most appropriate therapy and monitoring plans based on patient-specific information and the most current guidelines. 

Complex Case: Status Epilepticus and Cardiopulmonary Resuscitation
ACPE Number: 0204-0000-23-993-H01-P

• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions and needs, including status epilepticus, cardiopulmonary resuscitation, and sedation/analgesia.
• Differentiate treatment options in cardiopulmonary arrest based upon patient presentation.
• Select the appropriate dose and route of administration for medications.
• Assess the need and processes for reporting adverse drug events.
• Identify cultural considerations related to treatment and counseling of the pediatric population.
• Distinguish between the four preceptor roles. 

Select Topics in Pediatric Critical and Emergency Care
ACPE Number: 0204-0000-23-994-H01-P

• Interpret diagnostic and/or laboratory tests, vital signs, and clinical presentation of a pediatric patient with traumatic brain injury or select toxicological emergencies (e.g., acetaminophen, ethylene glycol).
• Develop the most appropriate therapy and monitoring plans based on patient-specific information and the most current guidelines.
• Develop appropriate medication dosing plans for a pediatric patient on ECMO.
• Develop plans to manage underlying disorders. 

Select Topics in Pediatric Neurology and Psychiatry, Part 1
ACPE Number: 0204-0000-23-995-H01-P

• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with migraines, autism, cerebral palsy, depression, or anxiety.Evaluate patients for drug-related problems and response to therapy.
• Identify appropriate modifications of patient-specific treatment plans based on follow up assessment. 

Select Topics in Pediatric Neurology - Part 2, Focus on Seizures
ACPE Number: 0204-0000-23-996-H01-P

• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with febrile seizures, neonatal seizures, infantile spasms, absence seizures, and Lennox-Gastaut syndrome.
• Evaluate patients for drug-related problems.
• Identify appropriate modifications of patient-specific treatment plans based on follow up assessment. 

Complex Case: Diabetic Ketoacidosis
ACPE Number: 0204-0000-23-997-H01-P

• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including diabetic ketoacidosis, type 1 diabetes mellitus, and urinary tract infection.
• Calculate maintenance and replacement fluid requirements and urine output.
• Identify factors affecting medication adherence.
• Recommend appropriate dosing of insulin based on patient age and weight.
• Select an effective method of delivery for insulin. 

Statistics, Evidence-Based Medicine and Clinical Trial Design
ACPE Number: 0204-0000-23-998-H04-P

• Interpret clinical and statistical significance based on specified excerpts of studies.
• Assess if appropriate statistical tests have been used.
• Assess whether the study applies to a specified patient population.
• Explain the levels of quality of evidence used to develop practice guidelines. 

Complex Case: Pneumonia and Septic Shock
ACPE Number: 0204-0000-23-999-H01-P

• Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including pneumonia, septic shock, and acute kidney injury.
• Calculate creatinine clearance, fluid requirements, and urine output in pediatric patients.
• Apply scoring systems to assess pediatric patients.
• Select appropriate dosing for medications based on renal dysfunction and/or replacement modalities.
• Differentiate vital signs between stable and critically ill pediatric patients. 

Select Topics in Pediatric Infectious Diseases - Part 1
ACPE Number: 0204-0000-23-619-H01-P

• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a well-appearing febrile infant.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with otitis media.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with bronchiolitis.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with tuberculosis.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with meningitis.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with pneumonia. 

Select Topics in Pediatric Infectious Diseases - Part 2
ACPE Number: 0204-0000-23-620-H01-P

• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with HIV, Herpes Simplex Virus Types 1 and 2, or systemic fungal infections. 

Regulatory and IRB Considerations
ACPE Number: 0204-0000-23-621-H03-P

• Identify appropriate off-label use of medications in the pediatric population.
• Recognize IRB requirements for documentation of clinical studies.
• List characteristics of patients who require informed assent/consent.
• Recognize federal legislation relevant to the use of medications in pediatric patients.

The Core Therapeutic Modules Review Package consists of 3 activities in which faculty review clinical topics and practice skills using a case-based approach. And provides up to 3 contact hours of continuing pharmacy education credit. The activities are designed to assist the learner in identifying knowledge gaps in preparation for a pharmacy specialty board examination. In addition to a recorded presentation, each activity includes links to resources for further self-study and a practice test developed in the same format and rigor as the specialty exam. 

After participating in these CPE activities, learners should be able to:

Select Topics in Pediatric Cardiovascular Disease
ACPE #: 0204-0000-22-630-H01-P

• Interpret signs, symptoms and diagnostic tests in a pediatric patient with congenital heart disease (specifically VSD, ASD, TOF, coarctation of aorta, and hypoplastic left heart) or Kawasaki disease.
• Identify drug-related problems, including drug interactions.
• Develop the most appropriate therapy and monitoring plans based on patient-specific information and the most current guidelines.
• Use PALS to determine appropriate therapy for bradycardia and tachycardia. 

Select Topics in Pediatric Infectious Diseases Part 1
ACPE #: 0204-0000-22-631-H01-P

• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a well-appearing febrile infant.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with otitis media.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with bronchiolitis.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with tuberculosis.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with meningitis.
• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with pneumonia.

Select Topics in Pediatric Neurology Part 2 - Focus on Seizures
ACPE #: 0204-0000-22-632-H01-P

• Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with febrile seizures, neonatal seizures, infantile spasms, absence seizures, and Lennox-Gastaut syndrome.
• Evaluate patients for drug-related problems.
• Identify appropriate modifications of patient-specific treatment plans based on follow up assessment. 

Teia Brandenburg, PharmD, BCPPS
Clinical Pharmacist – Child Neurology
University of Kentucky Healthcare
Lexington, Kentucky 

Jennifer Dannelley, PharmD
Pediatric Cystic Fibrosis Coordinator
OU College of Medicine, Department of Pediatrics
Oklahoma City, Oklahoma 

Lea Eiland, PharmD, BCPS, BCPPS, FASHP, FPPA
Associate Department Head
Auburn University Harrison College of Pharmacy
Auburn, Alabama 

Kaitlin Hughes, PharmD, BCPPS
Clinical Pharmacist Pediatric Critical Care
Riley Hospital for Children at IU Health
Indianapolis, Indiana 

Peter N. Johnson, PharmD, BCPPS,  FPPA, FCCM, FASHP*
Professor of Pharmacy Practice
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma 

Michelle Kussin, PharmD, BCOP
Co-director, Pediatric Antimicrobial Stewardship Program
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana 

Kevin Lonabaugh, PharmD, BCACP, BCPPS, AAHIVP, AE-C
Ambulatory Clinical Pharmacist - Pediatric and Adult Cystic Fibrosis/Pulmonary
Charlottesville, Virginia 

Erin Martin, PharmD, BCPS, BCPPS
Pediatric Pharmacy Clinical Specialist
MU Health Care Women’s Hospital
Columbia, Missouri 

Rachel S. Meyers, PharmD, BCPPS, BCPS, FPPAG
Clinical Professor
Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey
Pediatric Pharmacist
Saint Barnabas Medical Center
Piscataway, New Jersey 

Jamie L. Miller, PharmD, BCPPS, BCPS, FPPAG*
Associate Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma 

Misty Miller, PharmD, BCPS, AAHIVP
Associate Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma 

Ashley Nebbia, PharmD, BCCPS
Clinical Pharmacist
Physicians Regional Medical Center
Naples, Florida 

Lane Nguyen, PharmD, BCOP
Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York 

Kate Reichert, PharmD, BCCPS
Pediatric Oncology Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York 

Ashley Sabus, PharmD, BCOP
Clinical Pharmacist, Ambulatory Neuro-Oncology/Hemotology/Ancilary Services
Children's Hospital Colorado
Aurora, Colorado 

Jennifer Thackray, PharmD, BCPPS, BCPS*
Pediatric Oncology Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York 

Lisa Thames, PharmD, BCPS
Assistant Director, Pharmacy Services
UF Health Shands Hospital
Gainesville, Florida

*Content matter experts

Michelle Abalos, PharmD
Susan R. Dombrowski, MS, RPh
Kristi Hofer, PharmD

Hakeem Abayomi, PharmD, BS, BCPS, BCPPS, BCIDP, BCCCP
Erin Anderson, PharmD, BCPPS
Mei Bell, PharmD, BCPS, BCPPS
Kristin Bohannon, PharmD, BCPPS
Nikki Burleyson, PharmD, BCPS, BCPPS
Amanda Cavness, PharmD, BCPPS
Ka Chau, PharmD, BCPPS
Melissa Cook, PharmD, BCPPS
Aaron Cooper, PharmD, BCPPS
Jesse Cramer, PharmD, BCPPS
Melissa Cwiklinski, PharmD, BCPPS
Mackenzie DeVine, PharmD, BCPPS
Darrin Dillingham, PharmD, BCPPS
Elizabeth Farrington, PharmD, BCPS, BCNSP, BCPPS
Julianna Featherly, PharmD, BCPPS
Anna Felmer, PharmD, BCPPS
Kristen Finical, PharmD, BCPPS
Jessica Frye, PharmD, BCPPS
Nicole Goosby, PharmD, BCPPS, AAHIVP
Kristie Gormley, PharmD, MPH, BCPS, BCPPS
Katherine Greenhill, PharmD, BCPPS
Gina Gries, PharmD, BCPS, BCPPS
Sarrah Hein, PharmD, BCPPS
Christina Hellauer, PharmD, BCPPS
Gennaro Hernandez, PharmD, BCPPS
Pui Man (Julia) Ho, PharmD, BCPPS
Amy Holmes, PharmD, BCPPS
Katie Hughes, PharmD, BCPPS
Chris Kennie-Richardson, PharmD, BCPPS
Malia Kleespies, PharmD, BCPPS
Danielle Koubek, PharmD, BCPPS
Lydia Kouletsis, PharmD, BCPPS
Cindy Lai, PharmD, BCPPS
Biljana Lanier, BSPharm, BCPPS
Jessica Ma, PharmD, BCPPS
Terique McKenzie, PharmD, BCPPS
Dylan Mochizuki, PharmD, BCPPS
Jennifer Morris Daniel, PharmD, BCPPS, FCCM
Cody Moseman, PharmD, BCPPS
Zarema Muratova, BPharm, BCPPS
Lane Nguyen, PharmD, BCPPS
Lucas Orth, PharmD, BCPPS
Nicole Palazzolo, PharmD, BCPPS
Paul Paratore, PharmD, BCPPS
Seema Patel, BCPPS
Mandy Penland, PharmD, BCPPS
Tasha Porter, PharmD
Kimberly Raschke, PharmD, BCPPS
Melissa Ray, PharmD, BCPS, BCPPS
Marie Rossique-Gonzalez, PharmD, BCPPS
Justin Sheets, PharmD, BCPPS
Anna Simmont, PharmD, BCPS, BCPPS
Ashley Siryk, PharmD, BCPPS
Stephanie Spikes, PharmD, BCPPS
Mary Stoltz, PharmD, BCPPS
Melvis Tabe, PharmD, BCPPS
Erin Terranova, PharmD, BCPS, BCPPS
Carline Vieux-Laguerre, PharmD, BCPPS
Amanda Waldeck, PharmD, BCPS, BCPPS
Aspen Wall, PharmD, BCPPS

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity. 

All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity. 

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

These activities were developed by ASHP.